Kristina Burow

Kristina Burow

Net worth: 6 M $ as of 31/05/2026

53 year
Health Technology
Finance
Commercial Services

Profile

Ms. Kristina M.
Burow is an Independent Director at Neumora Therapeutics, Inc., an Independent Director at Boundless Bio, Inc., an Independent Director at Scholar Rock Holding Corp., a Managing Director at ARCH Venture Partners LP and a Managing Director at ARCH Venture Partners LLC.
She is on the Board of Directors at Neumora Therapeutics, Inc., Autobahn Therapeutics, Inc., Boundless Bio, Inc., Scholar Rock, Inc., Scholar Rock Holding Corp., Architect Therapeutics, Inc., Asteroid Therapeutics, Inc., Magnet Biomedicine, Inc., Mirador Therapeutics, Inc., National Venture Capital Association, Orbital Therapeutics, Inc., Pretzel Therapeutics, Inc., Rome Therapeutics, Inc., Treeline Biosciences, Inc. and Trelys, Inc. Ms. Burow was previously employed as an Independent Director by Gossamer Bio, Inc., an Independent Director by Beam Therapeutics, Inc., an Independent Director by Vir Biotechnology, Inc., an Independent Director by Sienna Biopharmaceuticals, Inc., an Independent Director by Metacrine, Inc., an Independent Director by Unity Biotechnology, Inc., an Independent Director by Receptos, Inc., an Associate by Novartis Bioventure Fund, a Principal by Novartis Institute for Functional Genomics, Inc., and an Associate by Novartis Venture.
She also served on the board at Metsera, Inc., Vividion Therapeutics, Inc., BlackThorn Therapeutics, Inc., AgBiome LLC, Lycera Corp., Sapphire Energy, Inc., AgTech Accelerator Corp., Celgene Corp., Epirium Bio, Inc., Kilimanjaro Energy, Inc., LearnZillion, Inc., Limerick BioPharma, Inc. and Reactive Biosciences, Inc. She received her undergraduate degree from the University of California, Berkeley, a graduate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Columbia University College of Pharmaceutical Sciences and an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 1,17,710 ( 0.1% ) 6 M $ 31/05/2026
27/05/2026 47,717 ( 0.03% ) 88 276 $ 31/05/2026
20/04/2026 0 ( -.--% ) - $ 31/05/2026

Kristina Burow active positions

CompaniesPositionStart
SCHOLAR ROCK HOLDING CORPORATION Director/Board Member 01/08/2014
BOUNDLESS BIO, INC. Director/Board Member 01/02/2018
NEUMORA THERAPEUTICS, INC. Founder 01/01/2020
Private Equity Investor 01/01/2002
Corporate Officer/Principal 01/11/2011
Director/Board Member -
Director/Board Member 01/02/2018
Director/Board Member -
Director/Board Member -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Kristina Burow

CompaniesPositionEnd
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Kristina Burow's experience

Training of Kristina Burow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

40

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies40

Health Technology

Finance

Finance

Health Technology

Energy Minerals

Health Technology

Producer Manufacturing

Health Technology

Commercial Services

Process Industries

Consumer Services

Consumer Services

Finance

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Kristina Burow